Marketing-authorisation holder · Germany
Csl Behring Gmbh
89 medicines in 5 countries, as authorisation holder and manufacturer.
Loading your page…
Loading your page…
Marketing-authorisation holder · Germany
89 medicines in 5 countries, as authorisation holder and manufacturer.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine in the registers under its name, current ones first.
1–25 of 89
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| Afstyla | Antihemophilic factor | EU (EMA) | Authorised | 2017 |
| AFSTYLAPolvere e solvente per soluzione iniettabile | Antihemophilic factor | Italy | Authorised | |
| Afstyla 1000 IE poeder en oplosmiddel voor oplossing voor injectiePoeder en oplosmiddel voor oplossing voor injectie | Antihemophilic factor | Netherlands | Authorised | 2017 |
| Afstyla 1500 IU/ml, poeder en oplosmiddel voor oplossing voor injectiePoeder en oplosmiddel voor oplossing voor injectie | Antihemophilic factor | Netherlands | Authorised | 2017 |
| Afstyla 2000 IE poeder en oplosmiddel voor oplossing voor injectiePoeder en oplosmiddel voor oplossing voor injectie | Antihemophilic factor | Netherlands | Authorised | 2017 |
| Afstyla 250 IE poeder en oplosmiddel voor oplossing voor injectiePoeder en oplosmiddel voor oplossing voor injectie | Antihemophilic factor | Netherlands | Authorised | 2017 |
| Afstyla 2500 IE poeder en oplosmiddel voor oplossing voor injectiePoeder en oplosmiddel voor oplossing voor injectie | Antihemophilic factor | Netherlands | Authorised | 2017 |
| Afstyla 3000 IE poeder en oplosmiddel voor oplossing voor injectiePoeder en oplosmiddel voor oplossing voor injectie | Antihemophilic factor | Netherlands | Authorised | 2017 |
| Afstyla 500 IE poeder en oplosmiddel voor oplossing voor injectiePoeder en oplosmiddel voor oplossing voor injectie | Antihemophilic factor | Netherlands | Authorised | 2017 |
| ALBUMEONSoluzione per infusione | Albumin | Italy | Authorised | |
| Albumeon 200 g/l otopina za infuzijuotopina za infuziju | Albumin | Croatia | Marketed | 2018 |
| ALBUREXSoluzione per infusione | Albumin | Italy | Authorised | |
| Alburex 20, 200 g/l, oplossing voor infusieOplossing voor infusie | Albumin | Netherlands | Authorised | 2010 |
| Alburex 5, 50 g/l, oplossing voor infusieOplossing voor infusie | Albumin | Netherlands | Authorised | 2010 |
| ANDEMBRYSoluzione per infusione | Garadacimab | Italy | Authorised | |
| Andembry | Garadacimab | EU (EMA) | Authorised | 2025 |
| ANDEMBRY 200 mg oplossing voor injectie in voorgevulde penOplossing voor injectie | Garadacimab | Netherlands | Authorised | 2025 |
| ANDEMBRY 200 mg oplossing voor injectie in voorgevulde spuitOplossing voor injectie | Garadacimab | Netherlands | Authorised | 2025 |
| BERIATEPolvere e solvente per soluzione iniettabile/ per infusione | Antihemophilic factor | Italy | Authorised | |
| Beriate 1000 IU prašak i otapalo za otopinu za injekciju ili infuzijuprašak i otapalo za otopinu za injekciju/infuziju | Antihemophilic factor | Croatia | Not marketed | 2017 |
| Beriate 2000 IU prašak i otapalo za otopinu za injekciju ili infuzijuprašak i otapalo za otopinu za injekciju/infuziju | Antihemophilic factor | Croatia | Not marketed | 2017 |
| Beriate 250 IU prašak i otapalo za otopinu za injekciju ili infuziju*prašak i otapalo za otopinu za injekciju/infuziju | Antihemophilic factor | Croatia | Not marketed | 2017 |
| Beriate 500 IU prašak i otapalo za otopinu za injekciju ili infuzijuprašak i otapalo za otopinu za injekciju/infuziju | Antihemophilic factor | Croatia | Not marketed | 2017 |
| BERINERTPolvere e solvente per soluzione iniettabile | Inibitore umano c1-esterasi | Italy | Authorised | |
| Berinert 1500 IE, poeder en oplosmiddel voor oplossing voor injectiePoeder en oplosmiddel voor oplossing voor injectie | C1-esteraseremmer | Netherlands | Authorised | 2021 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Netherlands | 36 | 36 | 0 | CompaniesAll medicines |
| Italy | 18 | 18 | 0 | CompaniesAll medicines |
| Croatia | 14 | 14 | 0 | CompaniesAll medicines |
| Romania | 13 | 0 | 13 | CompaniesAll medicines |
| European Union (EMA) | 8 | 8 | 0 | CompaniesAll medicines |
Also in the registers of Brazil, Canada, Serbia, Singapore, Spain, United Kingdom, United States
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Source: European Medicines Agency (EPAR data).
Licence: EMA reuse policy (source acknowledgement required)
Fuente de la información: AEMPS (CIMA).
Licence: AEMPS open data reuse with attribution
Anvisa, official medicine/API manufacturer factual export, HTTP source version Fri, 09 Oct 2026 08:21:54 GMT, acquired 2026-10-09; exact unmodified native identifiers and fields preserved.
Licence: Brazil federal factual open-data reuse; Decreto 8777/2016 consolidated article 4 and third-party exceptions
Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA presentaciones, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 1 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:47.757811+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Licence: Open Government Licence v3.0; exact Crown copyright 2026 publication grant
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 2 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:48.423930+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Licence: Open Government Licence v3.0; exact Crown copyright 2026 publication grant
HALMED, Baza lijekova, source export 08.10.2026., acquired 2026-10-08; factual structured adaptation; Otvorena dozvola RH, NN 67/2017.
Licence: Otvorena dozvola RH
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/3815901/Classe_A_per_principio_attivo_31-05-2026.csv; HTTP Last-Modified Mon, 28 Sep 2026 08:46:41 GMT; acquired 2026-10-13T17:21:06.055244+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/3815901/Classe_H_per_principio_attivo_31-05-2026.csv; HTTP Last-Modified Mon, 28 Sep 2026 08:46:40 GMT; acquired 2026-10-13T17:21:06.034935+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
Report an error or request removalCorrections from the company itself are welcome.
Agenzia Italiana del Farmaco (AIFA); https://drive.aifa.gov.it/farmaci/confezioni_fornitura.csv; HTTP Last-Modified Mon, 12 Oct 2026 23:02:44 GMT; acquired 2026-10-13T17:21:16.224007+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.
Licence: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim
Ministerul Sănătății, Catalogul public naţional al preţurilor, 18 iunie 2021, downloaded 2026-10-08 from data.gov.ro; CC BY 4.0; structured factual adaptation, code whitespace trimmed only where explicitly recorded.
Licence: Creative Commons Attribution 4.0 International (CC BY 4.0)
ALIMS, Registar humanih lekova, source 08.10.2026 02:00, downloaded 2026-10-08, https://data.gov.rs/sr/datasets/lekovi-za-upotrebu-u-khumanoj-meditsini/; structured factual adaptation; Serbian Open Data Licence.
Licence: Serbian Open Data Licence (sodl)
Contains information from HSA Listing of Registered Therapeutic Products accessed on 8 October 2026 from data.gov.sg, under Singapore Open Data Licence 1.0: https://data.gov.sg/open-data-licence
Licence: Singapore Open Data Licence
FDA Purple Book, September 2026 release; acquired 2026-10-10T15:29:54.330165+00:00; exact source fields retained with source-key projections.
Licence: FDA-created structured factual administrative metadata; public-domain policy with third-party exceptions
Other companies in the same group.
Ranked by their number of medicines.